TWiV 1046: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses wastewater surveillance data as a complement to emergency department visit data for tracking the incidence of influenza A and RSV, chatbot-delivered online intervention to promote seasonal Influenza vaccination during the COVID-19 pandemic, temporal assessment of disparities in California COVID-19 mortality by industry, modeling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City, can high COVID-19 vaccination rates in adults help protect unvaccinated children, Nirmatrelvir/Ritonavir use and hospitalizations or death in previously uninfected non-hospitalized high-risk population with COVID-19, Optimal duration of systemic corticosteroids in COVID-19 treatment, and vaccination after developing long COVID. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Wastewater surveillance data as a complement to tracking incidence of influenza A and RSV (CDC) Chatbot-delivered online intervention to promote seasonal influenza vaccination (JAMA) Temporal assessment of disparities in California COVID-19 mortality by industry (AOE) CDC/HICPAC's plan to weaken guidance for health care respiratory protection and infection control (NNU) Modelling the impact of a high-uptake bivalent booster scenario on COVID-19 burden (The Lancet) Can high COVID-19 vaccination rates in adults help protect unvaccinated children ? (ES) Paxlovid use and hospitalizations or death in previously uninfected high-risk population with COVID-19 (JID) Optimal duration of systemic corticosteroids in COVID-19 treatment (OFID) Vaccination after developing long COVID (IJID) Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1046 Dr. Griffin's COVID treatment summary ( pdf ) Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]